← Evidence map

ArticleBone marrow transplantation2023

Venetoclax is safe and tolerable as post-transplant maintenance therapy for AML patients at high risk for relapse.

Andrew Kent et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

36 papers cite it

2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 37185614